ACE-031 is an investigational protein therapeutic that builds muscle tissue and increases power by inhibiting signaling of a cell surface receptor called the activin receptor type IIB .D., Chief Medical Officer at Acceleron. ‘DMD patients suffer from progressive muscles weakness that gradually impairs their capability to walk, breathe and live independently voluntarily, and treatment with ACE-031 has the potential to improve muscle strength and slow the progression of the condition.’ ‘In preclinical research in the mdx mouse style of DMD, ACE-031 has shown potent results on increasing muscle tissue,’ stated Jasbir Seehra, PhD, Chief Scientific Officer and co-founder of Acceleron.If you notice the symptoms talked about above you should inform your physician right away. They’ll be in a position to investigate any suspicious coughs or spontaneous chest pains and determine if they’re connected to SCLC. This type of cancer is much even more treatable in the first stages so it is practical to act on any potential symptoms early and go see your doctor. Whilst every intention has been designed to make this article beneficial and accurate, it is designed for general information just.